About xtant medical holdings inc - XTNT
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.
XTNT At a Glance
Xtant Medical Holdings, Inc.
664 Cruiser Lane
Belgrade, Montana 59714
| Phone | 1-406-388-0480 | Revenue | 133.93M | |
| Industry | Medical Specialties | Net Income | 4.97M | |
| Sector | Health Technology | 2025 Sales Growth | 14.207% | |
| Fiscal Year-end | 12 / 2026 | Employees | 151 | |
| View SEC Filings |
XTNT Valuation
| P/E Current | 42.211 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 23.686 |
| Price to Sales Ratio | 0.878 |
| Price to Book Ratio | 2.155 |
| Price to Cash Flow Ratio | 9.41 |
| Enterprise Value to EBITDA | 10.316 |
| Enterprise Value to Sales | 0.963 |
| Total Debt to Enterprise Value | 0.223 |
XTNT Efficiency
| Revenue/Employee | 886,933.775 |
| Income Per Employee | 32,933.775 |
| Receivables Turnover | 4.738 |
| Total Asset Turnover | 1.425 |
XTNT Liquidity
| Current Ratio | 2.654 |
| Quick Ratio | 1.627 |
| Cash Ratio | 0.588 |
XTNT Profitability
| Gross Margin | 62.925 |
| Operating Margin | 5.439 |
| Pretax Margin | 5.227 |
| Net Margin | 3.713 |
| Return on Assets | 5.291 |
| Return on Equity | 10.59 |
| Return on Total Capital | 6.242 |
| Return on Invested Capital | 7.658 |
XTNT Capital Structure
| Total Debt to Total Equity | 56.36 |
| Total Debt to Total Capital | 36.045 |
| Total Debt to Total Assets | 30.503 |
| Long-Term Debt to Equity | 26.893 |
| Long-Term Debt to Total Capital | 17.20 |